Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study to find out why certain people develop oesophageal cancer (ChOPIN)
We know that this is an especially worrying time for people with cancer and their family and friends. We have separate information about coronavirus and cancer. Please read that information alongside this page. We will update that information as guidance changes.
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at whether your genes affect your risk of developing cancer of the food pipe (oesophageal cancer). You can take part if you have Barrett’s oesophagus or oesophageal cancer. You can also take part if you have inflammation of the oesophagus (oesophagitis) caused by long term acid indigestion (reflux) or hiatus hernia.
More about this trial
There are several risk factors for oesophageal cancer. These include things such as lifestyle, the environment or
This study will collect blood samples from people who have reflux (also called erosive) oesophagitis, Barrett’s oesophagus or oesophageal cancer to study their
In this study, the researchers will collect blood samples from people to help find out possible causes of oesophageal cancer that are related to their genes.
The aims of the study are to find out why
- Some people develop Barrett’s oesophagus
- Some people with Barrett’s oesophagus then develop oesophageal cancer
You won’t get any direct benefit from taking part in this trial, nor will it affect any treatment you have. But it will help researchers find out more about the genetic causes of oesophageal cancer.
Who can enter
You can enter this trial if you
- Have been diagnosed with reflux oesophagitis, Barrett’s oesophagus, hiatus hernia or oesophageal cancer
- Are willing to give a blood sample
- Are at least 18 years old
You will have a 2 blood samples taken about 3 years apart during a routine hospital visit.
You will have your blood tests at the hospital, during an outpatient appointment. You will not have to make an extra trip.
Your treatment and hospital appointments will carry on as normal.
As there are no treatments involved in this trial, the only side effect you may have is a small bruise when the blood sample is taken.
How to join a clinical trial
Professor Janusz Jankowski
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University Hospitals Plymouth NHS Trust
Plymouth University Peninsula Schools for Medicine and Dentistry